{"id":"https://openalex.org/W2890636166","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.7545","title":"Overall survival (OS) and transplantation (ASCT) utilization in real-world patients with relapsed/refractory diffuse large B-cell lymphoma (RR-DLBCL).","display_name":"Overall survival (OS) and transplantation (ASCT) utilization in real-world patients with relapsed/refractory diffuse large B-cell lymphoma (RR-DLBCL).","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2890636166","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.7545","mag":"2890636166"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.7545","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.7545","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.7545","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2890636166"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102912587","display_name":"Chadi Nabhan","orcid":"https://orcid.org/0000-0003-1740-299X","observed_orcids":["https://orcid.org/0000-0003-1740-299X"]},"institutions":[{"id":"https://openalex.org/I4210150323","display_name":"Cardinal Health (United States)","ror":"https://ror.org/03pd82777","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150323"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chadi Nabhan","raw_affiliation_strings":["Cardinal Health Specialty Solutions, Dublin, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardinal Health Specialty Solutions, Dublin, OH;","institution_ids":["https://openalex.org/I4210150323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108941277","display_name":"Andrew J. Klink","orcid":"https://orcid.org/0000-0003-3765-0448","observed_orcids":["https://orcid.org/0000-0003-3765-0448"]},"institutions":[{"id":"https://openalex.org/I4210150323","display_name":"Cardinal Health (United States)","ror":"https://ror.org/03pd82777","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150323"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Klink","raw_affiliation_strings":["Cardinal Health Specialty Solutions, Dublin, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardinal Health Specialty Solutions, Dublin, OH;","institution_ids":["https://openalex.org/I4210150323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045038832","display_name":"Choo Hyung Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150323","display_name":"Cardinal Health (United States)","ror":"https://ror.org/03pd82777","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150323"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Choo Hyung Lee","raw_affiliation_strings":["Cardinal Health Specialty Solutions, Dublin, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardinal Health Specialty Solutions, Dublin, OH;","institution_ids":["https://openalex.org/I4210150323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113253702","display_name":"Jalyna R. Laney","orcid":"https://orcid.org/0009-0005-9139-0597","observed_orcids":["https://orcid.org/0009-0005-9139-0597"]},"institutions":[{"id":"https://openalex.org/I4210150323","display_name":"Cardinal Health (United States)","ror":"https://ror.org/03pd82777","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150323"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jalyna R. Laney","raw_affiliation_strings":["Cardinal Health Specialty Solutions, Dublin, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardinal Health Specialty Solutions, Dublin, OH;","institution_ids":["https://openalex.org/I4210150323"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yin Yang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yin Yang","raw_affiliation_strings":["Kite, a Gilead company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite, a Gilead company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039349765","display_name":"Anna Purdum","orcid":"https://orcid.org/0000-0002-8587-2873","observed_orcids":["https://orcid.org/0000-0002-8587-2873"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna G. Purdum","raw_affiliation_strings":["Kite, a Gilead company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite, a Gilead company, Santa Monica, CA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"7545","last_page":"7545"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-diffuse-large-b-cell-lymphoma","display_name":"relapsed/refractory diffuse large B-cell lymphoma","score":0.9589999914169312},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9879999756813049},{"id":"https://openalex.org/keywords/transplant-utilization","display_name":"transplant utilization","score":0.6259999871253967},{"id":"https://openalex.org/keywords/early-recurrence","display_name":"early recurrence","score":0.7179999947547913},{"id":"https://openalex.org/keywords/late-recurrence","display_name":"late recurrence","score":0.8360000252723694},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.8889999985694885},{"id":"https://openalex.org/keywords/da-epoch-r","display_name":"DA-EPOCH-R","score":0.972000002861023},{"id":"https://openalex.org/keywords/community-based-care","display_name":"community-based care","score":0.5370000004768372},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6930000185966492},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8664496541023254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6299662590026855},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6070843935012817},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5515817403793335},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.537814736366272},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4915178716182709},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.48867276310920715},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4763762652873993},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.414470374584198},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36121928691864014},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3396458029747009},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.17291802167892456}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.7545","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.7545","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.7545","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2556207462","https://openalex.org/W2567396348","https://openalex.org/W2560168657","https://openalex.org/W2231302477","https://openalex.org/W4389219698","https://openalex.org/W3096535545","https://openalex.org/W3103667486","https://openalex.org/W7155616623","https://openalex.org/W2787744436","https://openalex.org/W2986154340"],"abstract_inverted_index":{"7545":[0],"Background:":[1],"Many":[2],"patients":[3],"(pts)":[4],"with":[5,48,63,231,290,300,326],"RR-DLBCL":[6,49,327],"treated":[7,50,62],"in":[8,26,53,115,166,353,356,367],"the":[9,20,27,59,184,349],"real-world":[10,46,324,358],"are":[11],"not":[12,272],"offered":[13],"ASCT":[14,23,106,266,347],"despite":[15],"its":[16],"curative":[17],"potential.":[18],"Understanding":[19],"impact":[21],"of":[22,100,125,128,133,236,255,294,306,310,315,323,336,346],"on":[24,80],"OS":[25,144,249,258,288,303,351],"real":[28],"world":[29],"is":[30],"critical":[31],"to":[32,40,162,175,240,268],"better":[33],"position":[34],"novel":[35,365],"therapies":[36,366],"as":[37,136],"an":[38,361],"alternative":[39],"ASCT.":[41,241,342],"Methods:":[42],"We":[43],"retrospectively":[44],"analyzed":[45],"pts":[47,223,238,244,325,339,355],"between":[51],"1/1/10-12/31/16":[52],"126":[54],"community-based":[55],"hematology/oncology":[56],"practices":[57],"across":[58],"US.":[60],"Pts":[61,102,111],"first":[64,246],"line":[65,293],"(1L)":[66],"R-CHOP":[67],"or":[68,117],"DA-EPOCH-R":[69],"were":[70,103,119,145,155,196],"grouped":[71],"into":[72],"2":[73],"categories:":[74],"early":[75,206],"relapse":[76,91,176],"(progressive":[77],"disease":[78],"[PD]":[79],"treatment":[81,94],"within":[82],"365":[83],"days":[84,96],"from":[85,97,121,253],"completing":[86],"last":[87,98],"cycle)":[88],"and":[89,150,180,194,208,313,348],"late":[90,214],"(any":[92],"2L":[93,116,305],"366-730":[95],"cycle":[99],"1L).":[101],"stratified":[104],"whether":[105],"was":[107,189,250,259],"performed":[108],"after":[109],"2L.":[110,256],"receiving":[112],"rituximab":[113],"monotherapy":[114],"later":[118],"excluded":[120],"analysis.":[122],"A":[123],"period":[124],"\u22656":[126],"months":[127],"clinical":[129],"inactivity":[130],"at":[131,171,245,304],"end":[132],"follow-up":[134],"served":[135],"a":[137,225,301],"proxy":[138],"for":[139,164,229,297,318,332,364],"death.":[140],"Median":[141,257,287],"(95%":[142,284],"CI)":[143],"estimated":[146,156],"by":[147,157],"Kaplan-Meier":[148],"method,":[149],"adjusted":[151,278],"hazard":[152,160],"ratios":[153],"(HR)":[154],"Cox":[158],"proportional":[159],"models":[161],"adjust":[163],"differences":[165],"pt":[167],"characteristics":[168],"(sex,":[169],"age":[170,188],"DLBCL":[172],"diagnosis,":[173],"time":[174],"(2L),":[177],"1L":[178],"R-CHOP,":[179],"comorbidities).":[181],"Results:":[182],"For":[183,242],"430":[185],"pts,":[186],"median":[187,248,302],"65":[190],"(range":[191],"18-84)":[192],"years":[193],"61%":[195],"male.":[197],"Following":[198],"1L,":[199],"over":[200],"86%":[201],"(n":[202,210,220,233],"=":[203,211,221,234,282],"371)":[204],"had":[205,213],"relapse,":[207,247],"14%":[209],"59)":[212],"relapse.":[215],"Across":[216],"all":[217,243,337],"lines,":[218],"33%":[219,322],"144)":[222],"received":[224,328],"salvage":[226,329],"regimen":[227],"intended":[228,331],"transplant,":[230],"38%":[232],"55)":[235],"these":[237],"proceeding":[239],"13.8":[251],"mo.":[252,274,317],"initiation":[254],"significantly":[260],"longer":[261],"among":[262],"those":[263,269],"who":[264,270],"underwent":[265,341],"compared":[267],"did":[271],"(21.4":[273],"vs":[275],"10.5":[276,307],"mo.;":[277],"P<":[279],"0.01);":[280],"HR":[281],"0.51":[283],"CI":[285],"0.32-0.81).":[286],"shortened":[289],"each":[291],"subsequent":[292],"therapy\u2014more":[295],"so":[296],"non-ASCT":[298,354],"group":[299],"mo.,":[308,312],"3L":[309],"9.4":[311],"4L+":[314],"3.9":[316],"non-ASCT.":[319],"Conclusions:":[320],"Although":[321],"regimens":[330],"ASCT,":[333],"only":[334],"13%":[335],"evaluable":[338],"eventually":[340],"The":[343],"low":[344],"utility":[345],"poor":[350],"rates":[352],"this":[357,368],"population":[359],"demonstrate":[360],"unmet":[362],"need":[363],"setting.":[369]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2890636166","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-09-27T00:00:00"}
